Company Overview

Update
Status:
Acquired by Eli Lilly
Founded:
2008
Founders:
Richard Aldrich, Christoph Westphal
Headquarters:
Cambridge, MA
Funding:
$55M
Categories:
Health and Wellness, Biotechnology
Description:
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.

Detailed Description

Update

Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.

Current Team (1)

Update

Past Team (5)

Update

Funding Rounds (2) - $55M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    840 Memorial Drive

    Cambridge, MA 02139

    USA

Images (1)

Update
  • Aca3e31ca816dd80a659beb87c2520dd